Summary We have recently used two-dimensional DNA typing to detect genetic alterations in breast tumours. This method, which is based on size separation in neutral gels and sequence separation in denaturing gradient gels followed by hybridisation analysis with mini-and microsatellite core probes, allows the simultaneous analysis of hundreds of allelic fragments in a very short time. Here we demonstrate the potency of this method for total genome scanning of the tumour genome by analysing a small series of breast cancers.
Somatic DNA changes play a critical role in the induction and progression of cancer. The results of molecular and epidemiological studies indicate that the induction of cancer in mammals requires the accumulation of several independent mutations (Peto et al., 1975) . Mutations affecting a wide range of cellular functions, including growth control, invasion, metastasis and the rate of mutation accumulation itself, can affect the progression of cancer. Such key genetic lesions in the tumour could be of clinical relevance for diagnosis or as a prognostic indicator. Early detection of the relevant changes, i.e. in the primary malignancy, could provide guidelines for better treatment, which is especially relevant in heterogeneous cancers such as breast cancer, nonsmall cell lung cancer and others. In such tumours combinations of mutations are seen. Although recently much information has been obtained on some of the most frequently occurring genomic changes, there is as yet no complete insight into the individual mutation spectra determining the biological properties of the tumour. Indeed, such basic insight would allow the development of combination therapies targeted to various steps in cancer progression (Russell, 1992) .
Thus far the lack of genome-scanning methods has effectively constrained the large-scale analysis of individual tumours for specific DNA changes that could be correlated with behavioural characteristics of the malignancy. We have recently demonstrated the usefulness of a two-dimensional (2-D) DNA electrophoretic approach for the rapid analysis of cancers for genomic change (Hovig et al., 1993) . In this system, which is based on separation by size followed by sequence-specific separation in denaturing gradient gels, large numbers of polymorphic micro-and minisatellite loci can be screened for deletions and amplifications through sequential hybridisation to core probes (Uitterlinden et al., 1989) . The large number of detectable genetic polymorphisms makes 2-D DNA typing unique among genome-scanning techniques, including other 2-D DNA separation techniques, such as the restriction landmark genome scanning (RLGS) technique (Hirotsune et al., 1992) . RLGS detects only 0.15% of polymorphic spots among all spots detected in human DNA of unrelated individuals (Y. Hayashizaki, personal communication). This effectively constrains application of RLGS in human genetic studies, including analysis of the tumour genome for instabilities. Two-dimensional DNA Preparation of 2-D DNA typing blots Two-dimensional separations of 10 jig of restriction enzymedigested genomic DNA were performed in 1 mm-thick polyacrylamide (PAA) gels (acrylamide-bisacrylamide, 37.5:1) using a gel apparatus that was essentially the same as previously described (Fischer & Lerman, 1979) . The first dimension was run in a neutral 6% gel at 50°C for 3 h at 200 V in 0.5 x TAE. The separation patterns were visualised by staining the gel with ethidium bromide (0.1 g ml-') for 30 min, followed by destaining for at least 10 min. From a given lane, the 0.4 to 4 kb region was used for 2-D separation. Lanes were cut out of the I-D gel and applied to a 6% PAA gel containing a 10-75% linear concentration gradient of denaturant (100% denaturant = 7.0 M urea, 40% formamide) parallel to the direction of electrophoresis. Gels were poured by mixing two solutions, containing the desired boundary denaturant concentrations, in a gradient maker (Pharmacia) with a peristaltic pump (BioRad). Electrophoresis was performed for 13.5 h at 60°C and 200 V (12 V cm-'). After 2-D electrophoresis, the DNA fragments in the separation patterns were first fragmented by irradiating the gel with 302 nm UV light for 4 min. Transfer to a nylon membrane (Hybond N+, Amersham) was achieved by semidry electroblotting at 400 mA (6-28 V) between horizontal ceramic (anode) and stainless-steel (cathode) plates with the cathode as the top place. Electroblotting was performed for 1.5 h between six Whatman 3MM paper sheets, which were soaked in 0.5 x TBE (89 mM Tris, 89 mM boric acid, 2 mM disodium EDTA). For denaturation of membranebound DNA fragments, filters were incubated in 0.4 M sodium hydroxide, 0.6 M sodium chloride for at least 1 h followed by neutralisation by rinsing with 2.5 x SSC (1 x SSC = 150 mm sodium chloride, 15 mM sodium citrate). Subsequently, the filter was air dried and irradiated for 1 min with 302 nm UV light to cross-link the DNA fragments to the filter.
Probe preparation and labelling The probes used in this study were microsatellite core probes (CAC)Q, (TCC)n, (GACA)n, (GATA)n, and TELO [= (TTAGGG)n], and minisatellite core probes 33.6, 33.15, INS and HBV-1. These probes and the protocol followed to prepare double-stranded DNA probes consisting of tandem repeat motifs have been described in detail elsewhere . Briefly, two partially complementary and overlapping oligonucleotides were individually phosphorylated by T4 kinase (Boehringer). Subsequently, the two oligonucleotides were mixed and allowed to anneal at 42°C for 1 h, followed by ligation according to standard procedures. After phenol extraction and ethanol precipitation, Hybridisation analysis Hybridisation analysis of filters was performed in glass tubes in a hybridisation oven (GFL) at 65°C. Filters were prehybridised in 7% SDS, 0.5 M sodium phosphate pH 7.2, 1 mM disodium EDTA for 5 min and hybridised in the same solution for 1 h. The filters were washed twice for 30 min at 65°C in 2.5 x SSC, 0.1% SDS, and exposed to Kodak XAR film in cassettes with intensifying screens for 2-48 h at -20°C. The filters were rehybridised after stripping at 100°C in 0.1 x SSC, 0.1% SDS, for 5 min and subsequent washing at 65°C in 0.1 x SSC, 0.1% SDS.
Interpretation of hybridisation patterns Tumour and normal DNAs were always run on one gel to facilitate interpretation. One-and two-dimensional DNA typing patterns were compared by eye independently by two investigators, for differences between tumour and normal tissues. Two-dimensional DNA typing patterns were compared using a grid, and spots, detected by the core probes used, that occur in all individuals analysed (constant spots; see Figure 5 ). In 2-D DNA typing differences were only scored if present in at least two independent experiments (see Results). Differences include increases (>2-fold) in spot intensity, referred to as gains/amplifications, decreases (>2-fold) in spot intensity referred to as losses and shifts (>5 mm) in spot position in either the x-or y-direction. Band and spot patterns, including the differences observed, were corrected for overlap among different core probes (i.e. a band or spot being detected by more than one core probe). The percentage overlap is expressed as the fraction of common bands/spots of the total detected by two core probes and was found to be 7% (range 6-12%) on average in 2-D DNA typing for the probes used here .
Results
Southern blot analysis As a general check we first performed Southern blot analyses of all tumour/blood combinations, using nine micro-and minisatellite core probes. Figure 1 shows examples after hybridisation with core probes 33.15 and TELO. All probes were found to generate multilocus patterns except (GACA)n, which detected fewer than ten bands per individual, and TELO, which detected a smear of large fragments (derived from the heterogeneous chromosome ends) and very few small fragments. After correction for overlap, in total an average of 170 bands were scored per individual. Overlap of bands detected was most prominent between (CAC)Q and 33.15 (30%), (CAC), and INS (24%), TCC and 33.6 (27%) and GATA, TCC and INS (27%).
In most tumours DNA changes were observed (on average five changes per individual for all probes), albeit with varying frequencies (Table II) . In total 73% of the changes detected were band losses in the tumour, while 27% were band gains and/or amplifications. Some probes were more efficient than others in detecting differences in relation to the total number of bands detected. While (GATA)" and HBV-1 detected relatively few differences (1.2% and 1.5% respectively), .
A second type of error is the lack of recurrence of a spot known to be present in a given DNA sample and the occurrence of spots due to artefacts. With respect to the former, it was found (from the same set of repeated analyses) that currently on average 1 out of 100 spots cannot be reproduced on the same gel; on different gels 1 out of 50 spots do not recur . This can be assessed by alkaline agarose gel electrophoresis of undigested genomic DNA (Sambrook et al., 1989) . Upon such analysis, 10 out of 18 tumour/normal DNA samples used for the Southern blot analyses appeared to be suitable for 2-D DNA typing.
The tumour/WBC combinations were analysed with four different probes: 33.15, 33.6, (CAC)" and TELO. The first three probes generated multilocus hybridisation patterns containing approximately 300 spots, while TELO resulted in a simple spot pattern consisting of about 50 spots. On average, 863 spots were scored for all probes together per individual after correction for spot overlap. Because of the much higher resolution of 2-D DNA typing, the overlap detectable is much less than for Southern blot analysis (overlap between any of the four probes varies from 6 to 12%). Figure 2 On average we detected 18 differences per individual for the four probes together (range 7-37). In all patients differences were observed (on average 2.1 %; range 1.1-5.2%) between tumour and normal (blood) tissue. The differences observed are summarised in Table III corresponding tumour tissue are shown in Figure 3 . To assess the reproducibility of the spot differences found, each comparison between tumour and normal DNA was performed at least in duplicate. Table IV shows the results of these replicate experiments. Spot differences found in hybridisation patterns of one gel could be reproduced in about 50% of the cases in the corresponding patterns from another gel. Only these reproducible spot differences were used in Table III , which is therefore an underestimate of the real number of differences. As in the Southern blot analysis, 74% of the differences appeared to be spot losses in the tumour, while 26% spot gains/amplifications were observed. Of the latter, 20% were amplifications, 5% involved gains and 1% were other types of differences such as shifts in spot position. Probes 33.15, 33.6 and TELO were more efficient in detecting spot differences than (CAC)", although TELO Figure 4 , in which the genetic changes detected with core probes 33.6, 33.15, (CAC)n, and TELO by Southern analysis were combined with those obtained by 2-D DNA typing with the same core probes (for the 1-D results 20% overlap was used to correct for the total number of bands detected). The figure indicates that the micro-and minisatellite core probes used have the same tendency but detect different spectra among patients with respect to the frequency of changes detected in a given patient. By compar- ing 2-D DNA typing patterns for each core probe for different patients we could detect differences occurring in more than one patient. Figure 5 shows the standardised 2-D gel positions of all such differences. In view of the small number of individual tumours analysed no attempt was made to test for significant associations between spot changes and node status or recurrence.
Discussion
In the present paper we demonstrate the potenty of 2-D DNA typing in genomic scanning of primary breast tumours. In each breast cancer analysed at least four genomic changes (Hirotsune et al., 1992) . We are currently extending the 2-D DNA typing analysis by including more tumour samples from the same series of patients (Andersen et al., 1992) . Since these tumours have also been genotyped for a number of loci, this allows the results on allelic imbalance obtained by 2-D DNA typing to be compared with those obtained using locus-specific markers.
New spots (gains) are most likely due to somatic mutations at the loci detected by the micro-and minisatellite core probes used. These loci include the hypervariable VNTR loci, mutations in which could arise through a number of mechanisms (Thein et al., 1987; Armour et al., 1989) . Such mutations do not necessarily occur in the tumour during development and progression, but could also reflect mutations pre-existing in the normal cells from which the tumour arose.
To circumvent the lack of immediate information on the locus involved in a particular change, it is possible to obtain spots of interest by direct isolation from the gel. A simple and rapid procedure to accomplish this has recently been developed (W.J.F. de Leeuw et al., submitted) . Therefore, large-scale 2-D DNA typing of tumours allows the rapid development of large series of probes specific for particular genomic changes in a given cancer. Alternatively, spots can be identified on the basis of co-segregation with known marker alleles, for example by using the CEPH panel. Preliminary results indicate that this is feasible and a 2-D DNA typing genetic map is presently under construction (Mullaart et al., manuscript in preparation). The availability of such a map will allow direct identification of variant spots in tumour tissue. Probes in the chromosomal region identified by the spots of interest can then be obtained from genomic libraries.
Using 2-D DNA typing the degree of genetic instability in a particular neoplasm can be assessed by scanning the total genome at high resolution. The higher genetic lability of tumours as compared with normal tissues is well documented (Nowell, 1976; Volpe, 1988) . It should be noted that any distinction among tumour genomes with respect to genetic variability might be due to differences in (clonal) heterogeneity of the tumour tissue. Multiclonal tumours in which each clone will differ at multiple loci will result in a 2-D DNA typing pattern with few consistent differences from normal. Breast cancer early stages may be heterogeneous and of polyclonal nature before convergence to monoclonality takes place (Borg, 1992) . It is not inconceivable that such an evolutionary process is reflected in the patterns of genetic changes we observed. However, any definite conclusions can only be drawn when results on many more samples become available.
The results obtained in this present study revealed a number of specific changes (amplifications and deletions) in breast cancers which had occurred in more than one patient. These spots correspond to alleles these patients happen to share in their normal DNA and which display allelic imbalance in the tumour. Such spots are therefore likely to be derived from loci more or less frequently involved in tumorigenesis and/or tumour progression. In this respect it should be noted that spot variants found to be on the same isotherm in the denaturing gradient (second dimension) could be alleles from the same locus (Uitterlinden & Vijg, 1991; Hovig et al., 1993) . These (polymorphic) spot variants ( Figure 5 ) are prime candidates for follow-up studies. Indeed, some of these spots have been isolated directly from the gel and are presently being tested as locus-specific probes on larger numbers of primary breast tumours for their suitability as prognostic indicators. The polymorphic nature of these probes allows their use in studying genetic susceptibility of breast cancer. Finally, the availability of ample genetic markers will greatly facilitate the identification and isolation of genes determining tumour behaviour and susceptibility.
